Founded in the United States in 1987, Johnson & Johnson Group's sub-brand specializing in the production of blood glucose monitoring products, introduced to the Chinese market in 1994, is committed to improving blood glucose monitoring technology and new product development and creation, providing various blood glucose monitoring products and monitoring management solutions
Wenjie OneTouch was originally affiliated to the century-old international brand Johnson & Johnson Group, and is a sub-brand of Johnson & Johnson specializing in the production of blood glucose monitoring products (Johnson & Johnson Wenjie blood glucose meter referred to as Johnson & Johnson blood glucose meter), and now Johnson & Johnson blood glucose meter has been renamed Wenjie blood glucose meter. In 1987, the OneTouch brand was born, which became a milestone in the development history of pocket blood glucose meters.
In 1994, Johnson & Johnson introduced the OneTouch to the Chinese market to help Chinese diabetics monitor and control their blood sugar. Since entering the Chinese market, OneTouch has not only been committed to continuously improving blood glucose monitoring technology and the development and creation of new products, but also actively engaged in diabetes education in China. OneTouch has established cooperative relations with hospitals across the country to promote diabetes education; Cooperate with medical associations in various provinces and cities to establish diabetes education centers; Carry out self-monitoring education for diabetic patients, free diabetes clinics and other activities; In cooperation with the Diabetes Branch of the Chinese Medical Association, we sponsored the National Diabetes Screening and Diabetes Academic Conference to further popularize the knowledge of diabetes self-monitoring and management.OneTouch's contribution to the cause of diabetes in China has been unanimously recognized by medical professionals and patients, and has now become a leader and innovator in the field of blood glucose monitoring. For more than 30 years, LifeScan, the manufacturer of OneTouch products, has been steadfast in its commitment to improving the quality of life for people living with diabetes.
In 2019, Leversconn Group, the manufacturer of Wenjie's OneTouch products, set up its Asian headquarters in Shanghai, relying on Leversconn (Shanghai) Medical Equipment Co., Ltd. to provide services for diabetic patients in the Asia-Pacific region. At present, there are more than 122 million diabetic patients in China, accounting for nearly one-tenth of the population, and the number of diabetic patients in China has ranked first in the world. In the face of such a huge market and the urgent need for blood glucose monitoring products from patients, the various blood glucose monitoring products and management solutions provided by Leversconn can meet the performance needs of patients. At the same time, the investment in the new headquarters demonstrates the strategic importance of the Chinese market for Leversconn and the company's determination to continue to expand and strengthen its leadership position in this key region.
For more than 40 years, Rafferscon has been steadfast in its focus on patient blood glucose monitoring and management, and has made unremitting efforts in diabetes health knowledge to improve the quality of life of people living with diabetes. Today, OneTouch continues to be at the forefront of R&D, promoting professional monitoring and management of diabetes, and continuously improving the R&D and creation of blood glucose monitoring technology and new products, with more than 20 million loyal users around the world. The contribution of OneTouch to the cause of diabetes has been unanimously recognized by professional medical staff and patients at home and abroad.
